首页> 外文期刊>Nature reviews Cancer >Hydroxyl Group Difference between Anthraquinone Derivatives Regulate Different Cell Death Pathways via Nucleo-Cytoplasmic Shuttling of p53
【24h】

Hydroxyl Group Difference between Anthraquinone Derivatives Regulate Different Cell Death Pathways via Nucleo-Cytoplasmic Shuttling of p53

机译:蒽醌衍生物之间的羟基差异通过P53的核 - 细胞质穿梭调节不同的细胞死亡途径

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Despite a number of measures having been taken for cancer management, it is still the second leading cause of death worldwide. p53 is the protein principally being targeted for cancer treatment. Targeting p53 localization may be an effective strategy in chemotherapy as it controls major cell death pathways based on its cellular localization. Anthraquinones are bioactive compounds widely being considered as potential anticancer agents but their mechanism of action is yet to be explored. It has been shown that the number and position of hydroxyl groups within the different anthraquinones like Emodin and Chrysophanol reflects the number of intermolecular hydrogen bonds which affect its activity. Emodin contains an additional OH group at C-3, in comparison to Chrysophanol and may differentially regulate different cell death pathways in cancer cell.
机译:背景:尽管癌症管理采取了许多措施,但它仍然是全世界死亡的第二个主要原因。 P53是主要是针对癌症治疗的蛋白质。 靶向P53本地化可能是化疗的有效策略,因为它基于其细胞定位控制主要细胞死亡途径。 蒽醌是广泛被认为是潜在的抗癌剂的生物活性化合物,但它们的行动机制尚未探索。 已经表明,羟基内的羟基内的数量和位置,如大黄素和甲醇等的不同的蒽醌反映了影响其活性的分子间氢键的数量。 与甲醇醇相比,Emodin含有C-3的另外的OH基团,并且可以差异地调节癌细胞中的不同细胞死亡途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号